Affordable Access

deepdyve-link
Publisher Website

Value of risk scores in the decision to palliate patients with ruptured abdominal aortic aneurysm.

Authors
  • Sweeting, M J1
  • Ulug, P2
  • Roy, J3
  • Hultgren, R3
  • Indrakusuma, R4
  • Balm, R4
  • Thompson, M M5
  • Hinchliffe, R J6
  • Thompson, S G1
  • Powell, J T2
  • 1 Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • 2 Vascular Surgery Research Group, Imperial College London, London, UK.
  • 3 Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden. , (Sweden)
  • 4 Department of Vascular Surgery, Academic Medical Centre, Amsterdam, The Netherlands. , (Netherlands)
  • 5 Stanford School of Medicine, Stanford, California, USA.
  • 6 Bristol Centre for Surgical Research, University of Bristol, Bristol, UK.
Type
Published Article
Journal
The British journal of surgery
Publication Date
Aug 01, 2018
Volume
105
Issue
9
Pages
1135–1144
Identifiers
DOI: 10.1002/bjs.10820
PMID: 30461007
Source
Medline
Language
English
License
Unknown

Abstract

The aim of this study was to develop a 48-h mortality risk score, which included morphology data, for patients with ruptured abdominal aortic aneurysm presenting to an emergency department, and to assess its predictive accuracy and clinical effectiveness in triaging patients to immediate aneurysm repair, transfer or palliative care. Data from patients in the IMPROVE (Immediate Management of the Patient With Ruptured Aneurysm: Open Versus Endovascular Repair) randomized trial were used to develop the risk score. Variables considered included age, sex, haemodynamic markers and aortic morphology. Backwards selection was used to identify relevant predictors. Predictive performance was assessed using calibration plots and the C-statistic. Validation of the newly developed and other previously published scores was conducted in four external populations. The net benefit of treating patients based on a risk threshold compared with treating none was quantified. Data from 536 patients in the IMPROVE trial were included. The final variables retained were age, sex, haemoglobin level, serum creatinine level, systolic BP, aortic neck length and angle, and acute myocardial ischaemia. The discrimination of the score for 48-h mortality in the IMPROVE data was reasonable (C-statistic 0·710, 95 per cent c.i. 0·659 to 0·760), but varied in external populations (from 0·652 to 0·761). The new score outperformed other published risk scores in some, but not all, populations. An 8 (95 per cent c.i. 5 to 11) per cent improvement in the C-statistic was estimated compared with using age alone. The assessed risk scores did not have sufficient accuracy to enable potentially life-saving decisions to be made regarding intervention. Focus should therefore shift to offering repair to more patients and reducing non-intervention rates, while respecting the wishes of the patient and family. © 2018 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.

Report this publication

Statistics

Seen <100 times